Target intelligence / Profile preview

Prostaglandin E synthase 3 pseudogene 5 (PTGES3P5)

Target: PTGES3P5
Molecular classification: Pseudogene, Other

Overview

Prostaglandin E synthase 3 pseudogene 5 (PTGES3P5) is classified as a pseudogene related to prostaglandin E synthase 3, a cytosolic enzyme involved in prostaglandin synthesis. Pseudogenes like PTGES3P5 do not encode functional proteins and are typically not biologically active or considered valid therapeutic targets. There is no evidence in current molecular databases or scientific publications to support that PTGES3P5 plays a role in biological processes, human disease, or can be targeted by drugs. Its inclusion as a target appears to be incorrect or misleading, and it should not be confused with the active enzyme "prostaglandin E synthase 3" (PTGES3).

Other names: Prostaglandin E synthase 3 (cytosolic) pseudogene 5PTGES3P5

Beyond the preview

Go deeper on Prostaglandin E synthase 3 pseudogene 5 (PTGES3P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prostaglandin E synthase 3 pseudogene 5 (PTGES3P5).

Explore the full profile